Dongfang Modern Agriculture (DFM)
|
|
- Caitlin Rose
- 5 years ago
- Views:
Transcription
1 Raising Orange Prices to Drive Up Profitability 4 October 2017 Paul Jensz pjensz@pacpartners.com.au Key Points Recommendation Spec. Buy DFM has managed to secure another ~920 hectares of plantations (380 camellia, 544 orange) with a total consideration of ~RMB 486m (~A$94m). Improved working capital position with trade receivables decreased from RMB 460m to now RMB 22m. Cash balance of RMB$157m (~A$30m) after paying 80% acquisition price (~RMB 389m). DFM had an average ROI of 36.5% over the past 3 years, but trading at a significant discount of ~70% to peers on earnings multiples. We reiterate our Speculative Buy recommendation with a 12 month price target of $1.07/share. Risk rating is High due to political risks. Previous Recommendation Spec. Buy Risk Rating High Current Share Price $ Month Price Target $1.07/share Price Target Methodology DCF Total Return (Capital + Yield) 37.5% DCF Valuation $1.84/share Market capitalisation $306m Liquidity Daily Value $0.24m Historical Financial Performance Investment Catalysts: Raising orange prices due to supply shortage. California Navel orange production has declined to ~70m cartons this year, down from ~93m cartons since according to the latest survey measurement from the California Department of Food and Agriculture (CDFA). This is due to regulatory pressure, declining bearing acreage, weather etc. As a result, DFM s oranges have been trading favourably with an average price of RMB 5.1/kg based on our estimation, which is on ~20% premium to usual selling price. Trading at 22% discounts to Net Tangible Asset backing of $1.02/share. Based on our analysis, DFM s NTA/share is around $1.02/share, but the stock is currently trading at $0.79/share, implying an 22% discount. Growing through acquisitions. During 1H 17, DFM acquired a 380-hectare camellia plantation and a 544- hectare navel orange plantation in Xingguo County, near existing plantations. These two acquisitions are forecasted to increase gross profit by ~A$8m in % of the purchase price ~RMB389m was already paid with in Jun 2017 with balance to be paid in Y/e (A$m) 2016A 2017F 2018F 2019F Revenue EBITDA NPAT EPS (cps) DPS (c) Dividend Yield 6.0% 7.4% 7.7% 7.6% Cash Balance Cash from Ops Source: Company reports and PAC Partners estimates DFM share price performance Recommendations: We initiated our coverage with a Spec. Buy rating in March 2017 based on peer comparison. With recent acquisitions, we believe DFM is well positioned to take advantage of raising orange prices. We reiterate our Speculative Buy recommendation with a 12 month price target of $1.07/share, which is the average of FY 16 s and FY 17 s NTA/share. Risk rating is High due to low liquidity compared to peers and high political/regulatory risks. Disclaimer: Disclaimer: PAC Partners will be paid a fee by the ASX under the ASX Equity Research Scheme for this research. Please refer to full disclaimer information on page 6. Source: Capital IQ & PAC Partners The information contained in this report is provided by PAC Partners to Wholesale Investors Only. The information contained in this report is to be read in conjunction with other important disclosures at the end of this document.
2 Peer Comparison Share Price Performance The share price performance of peers over the past 6 months have been divergent, with Costa (CGC) being the best performer: 65.00% 45.00% 25.00% 5.00% % % % Jan-2017 Feb-2017 Mar-2017 May-2017 Jun-2017 Aug-2017 Sep-2017 Dongfang Modern Agriculture Holding Group Limited (ASX:DFM) - Share Pricing Select Harvests Limited (ASX:SHV) - Share Pricing Costa Group Holdings Limited (ASX:CGC) - Share Pricing Elders Limited (ASX:ELD) - Share Pricing Ridley Corporation Limited (ASX:RIC) - Share Pricing Tassal Group Limited (ASX:TGR) - Share Pricing Source: Capital IQ and PAC Partners estimates Earnings Multiples DFM has been trading at significant discount to peers as illustrated below: DFM Peers Discount (%) EV / EBITDA EV / EBIT P / E % % % Source: Capital IQ and PAC Partners estimates Discounted Cash Flow (DCF) The recently acquired plantations are expected to increase Camellia and Orange productions by ~3,400 tonnes and ~19,000 tonnes respectively, and thereby bringing in RMB 120m (~A$23m) of sales revenue. We have assumed a modest average growth rate of ~3% over the mid-to-long term. Currently, DFM only has RMB 50m of short-term borrowings from the Chairman Mr Cai with no interest payments required. We estimated the weighted average cost of capital (WACC) to be 14.3%. As a result, the PV of equity value is ~RMB 3,927 (~A$740m), which implies a share price of A$1.84/share. Conclusion We initiated our coverage in March 2017 with a speculative Buy rating simply based on peer comparison. Through interactions with the management team, we have now understood the business model better, and hence are more confident in the cash flow of the business. We believe DFM is overly under-rated by the market. We reiterate our Speculative Buy recommendation with a 12 month price target of $1.07/share, which is the average of FY 16 s and FY 17 s NTA/share. Risk rating is High due to political/regulatory risks. Page 2
3 Dongfang Modern Ag Price $ 0.78 NFPOS m Market Cap $306.1 m PROFIT & LOSS (RMB m) Revenue , , , , ,211.1 EBITDA Depreciation & Amortisation (0.5) (11.8) (36.7) (43.1) (49.3) (50.5) (51.6) EBIT Net Interest Income tax (10.2) NPAT underlying Less non-controlling Interest Abnormal items NPAT Reported BALANCE SHEET (RMB m) Cash , ,654.5 PP&E Debtors Biological assets , , , , ,662.4 Other Assets Total Assets 1, , , , , , ,583.9 Borrowings Trade Creditors Other Liabilities Total Liabilities NET ASSETS 1, , , , , , ,476.9 Common Stock Cash Flow (RMB m) Operating EBITDA Change in Working Cap (33.7) (398.8) (8.6) 4.8 (9.7) Operating Cash Flow Capex (299.6) (215.4) (343.3) (391.0) (52.0) (102.0) (52.0) Free Cashflow (FCF) (265.7) Ord Dividends (0.5) (120.8) (124.7) (123.4) (126.7) New Share Issue New Debt/(Debt Paydown) (0.6) 1.8 Net Cashflow (262.6) Segment Analysis Revenue (RMB$m) Tangerine Pomelo Camellia Orange Unit Prices (RMB$/Kg) Tangerine Pomelo Camellia Orange Production (Tonnes) Tangerine 105, , , , , , ,520 Pomelo 53,763 54,384 51,374 49,450 49,450 49,450 49,450 Camellia 24,279 23,000 30,000 33,407 33,407 33,407 33,407 Orange 17,475 20,000 19,486 38,997 38,997 38,997 38,997 Plantation Areas (Hectares) Tangerine 3,751 4,417 4,817 4,817 4,817 4,817 4,817 Pomelo 1,433 1,433 1,433 1,433 1,433 1,433 1,433 Camellia 1,394 2,247 3,047 3,426 3,426 3,426 3,426 Orange ,084 1,084 1,084 1,084 Total 7,119 8,639 9,839 10,761 10,761 10,761 10,761 Page 3
4 Dongfang Modern Ag Date: Model Updated: 4-Oct-17 4-Oct-17 KEY RATIOS EBITDA Margin (%) 43.6% 45.3% 46.5% 45.5% 46.0% 46.2% 45.9% NPAT Margin (%) 43.7% 44.1% 42.0% 41.9% 42.0% 42.0% 41.8% ROA (%) y/e 28.8% 25.0% 19.7% 19.7% 17.6% 15.4% 14.1% ROE (%) y/e 30.4% 25.3% 21.9% 20.6% 18.3% 15.9% 14.6% ROI (%) y/e 41.6% 41.2% 26.7% 26.7% 27.3% 26.3% 26.8% NTA per share (A$) Eff Tax Rate (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Interest Cover (x) n/a n/a n/a n/a n/a n/a n/a Net Gearing (%) -27.1% -38.7% -16.2% -23.1% -33.2% -39.6% -45.8% VALUATION PARAMETERS Adj. EPS (A$cps) PE Adj (x) Enterprise Value (A$m) EV / EBITDA (x) EV / EBIT (x) Price / NTA DPS (A$cps) Dividend Yield (%) 0.0% 5.5% 6.5% 7.4% 7.7% 7.6% 7.8% Free Cash / Share (c) Price / FCF PS (x) VALUATION & SENSITIVITY PV of Cashflows 2017 to Risk Free Rate 3.0% PV of Term Year Cashflow 237 Equity Risk Premium 8.0% Net Debt -17 Equity Beta 1.50 PV of Equity 758 Cost of Equity 15.0% Cost of Debt 0.0% Terminal Growth 3.0% After Tax WACC 14.3% DCF Valution $ Month Price Target $ 1.07 Term. WACC Term. Growth 15.3% 14.3% 13.3% 12.3% 2.0% $1.66 $1.79 $1.96 $ % $1.68 $1.82 $1.99 $ % $1.70 $1.84 $2.02 $ % $1.72 $1.87 $2.06 $ % $1.74 $1.90 $2.10 $2.34 Board Members MAJOR SHAREHOLDERS % Hongwei Cai Chairman Cai Hongwei 56.2% Chiu (Charles) So CEO lan Mu Ltd 16.2% Ming Sing Barton Tso Executive Director Hammer Capital 4.1% Dan Lin Non-exec Director Prosper Rich Investment 2.5% Michael Wai-Man Choi Non-exec Director Merrill Lynch 2.4% Top % GROWTH PROFILE (YoY) Sales Revenue 24% 26% 10% 13% 3% -1% 3% EBIT 23% 27% 7% 10% 3% -1% 3% NPAT 24% 27% 5% 12% 3% -1% 3% EPS 46% -13% 12% 3% -1% 3% DPS 0% 17% 15% 3% -1% 3% Page 4
5 Contact Information CORPORATE FINANCE RESEARCH DEALING CRAIG STRANGER Managing Director PAUL JENSZ Director, Senior Industrial BRENDAN FOGARTY Corporate Sales Melbourne SEAN KENNEDY Corporate Finance ANDREW SHEARER Senior PHIL CAWOOD Institutional Sales Sydney ANTHONY STANI Corporate Finance ALEX SMITH SEBASTIAN JURD Senior advisor Sydney BROOKE PICKEN Equity Capital Markets LAWRENCE GRECH RYAN GALE Advisor Melbourne ROGER CHEN TOM FAIRCHILD Corporate Sales Melbourne IAN LEETE Corporate Sales Sydney MELBOURNE (Head Office) Level 10, 330 Collins Street, Melbourne VIC SYDNEY Level 9, 56 Pitt Street, Sydney NSW DANIEL GADALLA Desk Assistance Melbourne dgadalla@pacpartners.com.au SOL JONES Desk Assistant Sydney sjones@pacpartners.com.au Recommendation Criteria Investment View PAC Partners Investment View is based on an absolute 1-year total return equal to capital appreciation plus yield. A Speculative recommendation is when a company has limited experience from which to derive a fundamental investment view. Buy Hold Sel >20% 20% 5% <5% Risk Rating PAC Partners has a four tier Risk Rating System consisting of: Very High, High, Medium and Low. The Risk Rating is a subjective rating based on: Management Track Record, Forecasting Risk, Industry Risk and Financial Risk including cash flow analysis. Disclosure of Economic Interests The views expressed in this research report accurately reflect the personal views of Paul Jensz about the subject issuer and its securities. No part of the analyst's compensation was, is or will be directly or indirectly related to any recommendation or view expressed in this report. The following person(s) do not hold an economic interest in the securities covered in this report or other securities issued by the subject issuer which may influence this report: the author of this report a member of the immediate family of the author of this report Disclaimer PAC Partners Pty Ltd. ( PAC Partners or PAC ) is a Corporate Authorised Representative of PAC Asset Management Pty Ltd holder of an Australian Financial Services Licence (AFSL No ). The information contained in this report is provided by PAC Partners to Wholesale Investors only. Retail investor and third party recipients should not rely, directly or indirectly, on this report. Users of this research report should not act on any content or recommendation without first seeking professional advice. Whilst the report has been prepared with all reasonable care from sources which we believe are reliable, no responsibility or liability is accepted by PAC Partners, for any errors or omissions or misstatements however caused. Any opinions, forecasts or recommendations reflect our judgement and assumptions at the date of publication or broadcast and may change without notice. This report is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. This publication contains general securities advice. In preparing our Content it is not possible to take into consideration the investment objectives, financial situation or particular needs of any individual user. Access of this report does not create a client relationship between PAC Partners and the user. Before making an investment decision on the basis of this advice, you need to consider, with or without the assistance of a securities adviser, whether the advice in this publication is appropriate in light of your particular investment needs, objectives and financial situation. PAC and its associates within the meaning of the Corporations Act may hold securities in the companies referred to in this publication. PAC believes that the advice and information herein is accurate and reliable, but no warranties of accuracy, reliability or completeness are given (except insofar as liability under any statute cannot be excluded). No responsibility for any errors or omissions or any negligence is accepted by PAC or any of its directors, employees or agents. Any content is not for public circulation or reproduction, whether in whole or in part and is not to be disclosed to any person other than the intended user, without the prior written consent of PAC Partners. Disclosure of Corporate Involvement PAC Partners has in the previous 12 months carried out work on behalf of the Company described in this report and is currently being paid a monthly retainer its services. This report was prepared solely by PAC Partners. ASX did not prepare any part of the report and has not contributed in any way to its content. The role of ASX in relation to the preparation of the research reports is limited to funding their preparation, by PAC Partners, in accordance with the ASX Equity Research Scheme. ASX does not provide financial product advice. The views expressed in this research report may not necessarily reflect the views of ASX. To the maximum extent permitted by law, no representation, warranty or undertaking, express or implied, is made and no responsibility or liability is accepted by ASX as to the adequacy, accuracy, completeness or reasonableness of the research reports. PAC Partners and/or their associates may own securities of the Company described in this report. PAC Partners does and seeks to do business with companies covered in the research. PAC may receive commissions from dealing in securities. As a result, investors should be aware that PAC Partners may have a conflict of interest that could affect the objectivity of this report. For more information about PAC Partners please visit Page 5
Dongfang Modern Agriculture (DFM)
Is it too good to be true? 24 March 2017 Roger Chen rchen@pacpartners.com.au +61 3 8633 9868 Key Points Recommendation Spec. Buy Dongfang (DFM), founded in 2008, has become the one of the largest citrus
More informationAurora Labs (ASX: A3D) New Technologies Can Take Time
EQUITY RESE ARCH Key Points Aurora Labs (ASX: A3D) is an additive manufacturer, which designs and develops several types of 3D metal printers. Aurora Lab s made strong progress throughout the quarter signing
More informationNYSE: DBD ASX: MNW Share Price Source: CapitalIQ
Share Price Volume (Millions) E QUITY RESE AR C H Pathway Set Towards Profitability Key Points STL is the second largest independent ATM player, owns and operates ~2.9k ATMs. FY 17 has been a transformative
More informationFE Investments Group (FEI)
E QUITY RESE AR C H FE Investments Group (FEI) SME Lender: Proven Model, Strong Growth 5 July 2018 Erwin Tan ETan@pacpartners.com.au +61 2 9134 9188 KEY POINTS FEI is a founder-led licensed deposit-taking
More informationFEI E QUITY RESE AR C H. Shadowplay Upgrade to BUY. 8 January 2019 SPECULATIVE BUY KEY POINTS. Risk Rating
E QUITY RESE AR C H 8 January 2019 FEI Shadowplay Upgrade to BUY KEY POINTS After a protracted period in suspension, non-bank lender FEI reported a messy H1-19 result, which masked what is a strong underlying
More informationDongfang Modern Agriculture Holding Group Limited
Dongfang Modern Agriculture Holding Group Limited For the Half Year ended 30 June 2016 ACN 604 659 270 Level 12, 225 George Street, Sydney NSW 2000 Australia T:+61 7 32291633 E:enquiry@dfm.net.au Appendix
More informationTyranna Resources (TYX)
Promising Gold Discoveries 29 August 2016 Andrew Shearer ashearer@pacpartners.com.au +61 3 8633 9862 Key Points Tyranna (TYX) was formed out of the re-merger between IronClad Mining (IFE) and Trafford
More informationBrain Resource (BRC) Brain function leader moving towards consumers profitably. 11 February Paul Jensz
Medical Developments (CMP) Brain function leader moving towards consumers profitably 11 February 2016 Paul Jensz pjensz@pacpartners.com.au +61 3 8633 9864 Key Points Recommendation Spec Buy BRC has 30
More informationResetting expectations
Company update 13 May 2016 TPI ENTERPRISES (TPE) Resetting expectations We retain a BUY rating with a revised 12-month price target of $3.21 p/sh. We assess market conditions to imply a more gradual ramp
More informationInsurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates
11 May 2018 RECOMMENDATIONS AUB Group (AUB) Rating HOLD Risk Low Price Target $14.50 Share Price $14.17 Steadfast Group (SDF) Rating HOLD Risk Low Price Target $2.80 Share Price $2.88 RESEARCH ANALYST
More informationMEDICAL DEVELOPMENTS INTERNATIONAL LTD
MEDICAL DEVELOPMENTS INTERNATIONAL LTD No pain in Germany HOLD Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals 6 April 2018 COMPANY UPDATE Ticker MVP Stock Price $7.10 Target Price $8.08
More informationWisr Ltd (DirectMoney)
Wisr Ltd (DirectMoney) Interim result draws a line in the sand Wisr Limited (WZR.AX) is an online consumer lending platform competing in the rapidly growing marketplace-lending sector. The company has
More informationWisr Ltd (DirectMoney)
Wisr Ltd (DirectMoney) Strategic placement at 56% premium to previous close Wisr Limited (WZR.AX) is an online consumer lending platform competing in the rapidly growing marketplace lending sector. The
More informationAsset revaluation driven by almonds
Company update 20 July 2015 RURAL FUNDS GROUP (RFF) Asset revaluation driven by almonds We retain a BUY rating with a 12-month target of $1.15 p/unit. RFF is a listed property trust with a portfolio of
More informationRegional Express Holdings Ltd REX
20 February 2006 REX $1.15 Analyst Ken Fleming (613) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (613) 6224 9899 Fully diluted shares on issue 115.0M Market cap A$132.3M Performance & Valuation Last
More informationWINDLAB LTD HOLD. Lakeland financial close delayed again. Downgrade to HOLD. COMPANY UPDATE EVENT IMPACT INVESTMENT VIEW
WINDLAB LTD HOLD Lakeland financial close delayed again. Downgrade to HOLD. Utilities / Renewable Electricity 7 November 2018 COMPANY UPDATE Ticker WND Stock Price $1.180 Target Price $1.350 Forecast Capital
More informationPRICE $1.30 Regional Express Holdings Ltd REX
16 November 2006 PRICE $1.30 Regional Express Holdings Ltd REX Analyst Ken Fleming (03) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (03) 6224 9899 Fully diluted shares on issue 115M Market cap A$133M
More informationTechnology Metals Australia (TMT)
E QUITY RESE AR C H Technology Metals Australia (TMT) Positive Vanadium PFS 18 July 2018 Andrew Shearer ashearer@pacpartners.com.au +61 3 8633 9862 KEY POINTS With the release of the PFS for the Gabanintha
More information22 February 2018 Ian Munro
22 February 2018 Ian Munro imunro@ccz.com.au 03 8605 7902 Recommendation: BUY, target price $0.43 (from $0.50) Share price: $0.36 Market cap: $103.7m Year end June 2016A 2017A 2018E 2019E 2020E Sales ($m)
More informationDONGFANG MODERN AGRICULTURE HOLDING GROUP LIMITED
DONGFANG MODERN AGRICULTURE HOLDING GROUP LIMITED Annual Report 2016 The leading citrus company operating within the world's largest market ACN 604 659 270 2 P age Table of contents KEY HIGHLIGHTS 4 EXECUTIVE
More informationONEVIEW HEALTHCARE PLC
ONEVIEW HEALTHCARE PLC BUY 2017 Result Green Shoots Emerging Health Care Equipment & Services / Health Care Technology 28 February 2018 COMPANY UPDATE Ticker ONE Stock Price $1.900 Target Price $3.04 Forecast
More informationPraemium (PPS) COMPANY REPORT. Quartermaster
10 October 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.58 Share Price $0.45 SNAPSHOT Monthly Turnover $9.2mn Market Cap $162mn Shares Issued 399.6mn 52-Week High $0.54 52-Week
More informationWisr Ltd. New products to underpin growth
Wisr Ltd Company Update New products to underpin growth Wisr Limited (WZR.AX) is an online consumer lending platform focused on financial wellness and competing in the rapidly growing marketplace lending
More informationConsolidated Operations Group (COG)
Consolidated Operations Group (COG) 10 April 2018 Outperform Upgrade to OUTPERFORM - Inflection point nearing $0.10 Jason Palmer jpalmer@taylorcollison.com.au +618 8217 3965 Summary (AUD) Market Capitalisation
More informationPRICE $1.16 Regional Express Holdings Ltd REX
13 September 2006 PRICE $1.16 Regional Express Holdings Ltd REX Analyst Ken Fleming (03) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (03) 6224 9899 Fully diluted shares on issue 115.0M Market cap A$121.9M
More informationBLUE BOOK SERIES. Junior Resources. March 2008 Quarterly Review. Storm approaching thank goodness for China EXTRACT
Australian BLUE BOOK SERIES Junior Resources March 2008 Quarterly Review Storm approaching thank goodness for China EXTRACT Contents This is an extract from the March 2008 Junior Resources Quarterly Review.
More informationContango MicroCap Ltd (CTN)
Contango MicroCap Ltd (CTN) Listed Managed Investments June 2013 Quarterly Review WHO IS IIR? Independent Investment Research, IIR, is an independent investment research house based in Australia and the
More informationFor personal use only
Dongfang Modern Agriculture Holding Group Limited For the Half Year ended 30 June 2015 ACN 604 659 270 410/282 Victoria Ave, Chatswood NSW 2067 Australia T:+61 2 8964 8531 E: info@dongfangmodernagriculture.com.au
More informationPraemium (PPS) COMPANY REPORT. Model performance
14 August 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.58 Share Price $0.41 SNAPSHOT Monthly Turnover $9.5mn Market Cap $165mn Shares Issued 398.5mn 52-Week High $0.54 52-Week
More informationPerpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions
16 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation TS Lim 612 8224 2810 Perpetual (PPT) Oversold, upgrade to Buy Recommendation Buy (Hold) Price $42.09 Target (12 months) $47.50 (previously
More informationNoni B (NBL) SFH acquisition could be up to 60% EPS accretive. Key points. Risks and catalysts
Date Theme Company Update Company Noni B (NBL) SFH acquisition could be up to 6 EPS accretive Press reports today (Australian) suggest Noni B is a potential acquirer of Specialty Fashion Group (SFH), in
More informationBUY. China Suntien Green Energy [0956.HK] January 25, 2016
China Suntien Green Energy [0956.HK] Profit decline largely due to provision; Current valuation of 0.4x PBR already reflected significant impairment Suntien preannounced that its net profit in 2015 would
More informationMilton Corporation Ltd (MLT)
Milton Corporation Ltd (MLT) Listed Managed Investments June 2017 Quarterly Review WHO IS IIR? Independent Investment Research, IIR, is an independent investment research house based in Australia and the
More informationNanosonics Limited. Australia Health Care Equipment & Supplies. Growth outlook unchanged. Earnings Forecasts. Source Company, LINWAR Research
LINWAR Securities 30 August 2011 Nanosonics Limited Australia Health Care Equipment & Supplies Outperform (Unchanged) Price: Target Price: Stock's expected return (12mth) $0.57 $1.20 Capital growth 112.4%
More informationCochlear. Roberts replaced A$88.66 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation
AUSTRALIA COH AU Price (at 06:47, 26 May 2015 GMT) Outperform A$88.66 Valuation A$ 81.19 - DCF (WACC 8.0%, beta 1.0, ERP 5.0%, RFR 3.8%, TGR 3.0%) 12-month target A$ 95.00 12-month TSR % +9.8 Volatility
More informationKangaroo Island Plantation Timbers (KPT) BUY Share Price: A$2.15. NTA uplift buffers project delays Target Price: A$2.71
Kangaroo Island Plantation Timbers (KPT) BUY Share Price: A$2.15 NTA uplift buffers project delays Target Price: A$2.71 KPT has increased the carrying value of its standing timber to reflect higher timber
More informationListed Managed Investments
Australian MANAGED INVESTMENTS ANALYSIS Listed Managed Investments March 2009 Quarterly Review EXTRACT Environment for equity markets remain challenging but some positive signs emerge Contents This is
More informationCOMPUMEDICS LTD HOLD. CMP Downgrades FY17 Guidance COMPANY UPDATE EVENT KEY TAKE-AWAYS INVESTMENT VIEW
COMPUMEDICS LTD HOLD CMP Downgrades FY17 Guidance Health Care Equipment & Services / Health Care Equipment 7 July 2017 COMPANY UPDATE Ticker CMP Stock Price $0.560 Target Price $0.530 Forecast Capital
More informationCodan Limited (ASX: CDA)
Codan Limited (ASX: CDA) 1H18 Results March 2018 WHO IS IIR?, IIR, is an independent investment research house based in Australia and the United States. IIR specialises in the analysis of high quality
More informationAuckland International Airport
NEW ZEALAND AIA NZ Price (at 04:00, 27 Nov 2013 GMT) Neutral NZ$3.42 Valuation NZ$ 3.37 - DCF (WACC 8.0%, beta 0.9, ERP 7.0%, RFR 4.3%, TGR 3.0%) 12-month target NZ$ 3.37 12-month TSR % +2.6 Volatility
More informationAtCor Medical Holdings Limited (ACG)
Volume (million) AtCor Medical Holdings Limited (ACG) 30 March 2015 Speculative Buy Value Creation Ahead Post CPT1 Code Award $0.20 Marcus Hamilton mhamilton@taylorcollison.com.au +61 2 9210 1317 Summary
More informationHigh-Tech. Company Data. Data Source: FactSet
APP Securities Company Research 7 June 2018 Silex Systems Ltd SLX-ASX A$0.29 TARGET PRICE A$0.45 HOLD Silex Systems Ltd. is focused on the delivery of the SILEX Laser Enrichment technology for the global
More informationGenex Power (GNX) COMPANY REPORT. NAIF lined up for Stage 2
21 June 2018 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Speculative Price Target $0.37 Share Price $0.31 SNAPSHOT Monthly Turnover $2.5mn Market Cap $91mn Shares Issued 303.9mn 52-Week High $0.43 52-Week
More informationZip Co. Delivering against expectations. Last Price A$0.86 Target Price A$0.90 (Previously A$0.88) Recommendation Accumulate Risk Higher.
Delivering against expectations Z1P s Mar-18 qtrly report delivered well against our expectations. Positive operating cash flow for the qtr of $1.6m was a +$2.8m improvement qoq, despite the receivables
More informationEarnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation
AUSTRALIA CBA AU Price (at 06:10, 10 Sep 2013 GMT) Neutral A$73.63 Valuation A$ - DCF (WACC 10.3%, beta 1.0, ERP 5.0%, RFR 5.5%) 50.40 12-month target A$ 66.15 12-month TSR % -5.0 Volatility Index Low
More informationRecycling assets at a premium. Vector to sell non-auckland gas assets at a premium. We view the transaction as value accretive
Australasia New Zealand Utilities Institutional Research Breaking News Reuters Bloomberg Exchange Ticker VCT.NZ VCT NZ NZE VCT Recycling assets at a premium 9 November 015 Issued by: Craigs Investment
More informationPlatinum Asset Management (PTM)
24 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Recommendation Hold (unchanged) Price $5.10 Target (12 months) $4.90
More informationBLUE BOOK SERIES. Junior Resources. June 2008 Quarterly Review EXTRACT. Storm clouds darkening and China slowing
Australian BLUE BOOK SERIES Junior Resources June 2008 Quarterly Review EXTRACT Storm clouds darkening and China slowing Contents This is an extract from the June 2008 Junior Resources Quarterly Review
More informationNational Australia Bank
AUSTRALIA NAB AU Price (at 06:10, 27 Jul 2015 GMT) Outperform A$33.91 Valuation A$ - DCF (WACC 9.6%, beta 1.0, ERP 5.0%, RFR 5.8%) 37.74 12-month target A$ 39.39 12-month TSR % +22.1 Volatility Index Low
More informationZespri. Vote for change and SunGold licence sales underpin a strong outlook COMPANY RESEARCH. Private Wealth Research
COMPANY RESEARCH 8 MAY 218 Private Wealth Research Zespri Vote for change and SunGold licence sales underpin a strong outlook Key data Code Current price ZGL NZ$8.7 Over the past 6 months since our initiation
More informationLME copper inventories still climbing. Copper TC/RC s on a short up swing. Nickel moving higher
Base Metals Weekly News, Views, Prices and Comparisons 21 February 2011 Analysts Keith Williams 03 9640 3802 keith.williams@wilsonhtm.com.au Andrew Pedler 07 3212 1346 andrew.pedler@wilsonhtm.com.au James
More informationContango MicroCap Ltd (CTN)
Contango MicroCap Ltd (CTN) Listed Managed Investments June 2014 Quarterly Review WHO IS IIR? Independent Investment Research, IIR, is an independent investment research house based in Australia and the
More informationGeneration Healthcare REIT
AUSTRALIA GHC AU Price (at 06:13, 24 Aug 2015 GMT) Neutral A$1.65 Valuation - Sum of Parts A$ 1.51-1.59 12-month target A$ 1.59 12-month TSR % +1.8 Volatility Index Low GICS sector Real Estate Market cap
More informationMNF Group Limited (MNF)
MNF Group Limited (MNF) 16 February 2018 Outperform 1H18 Results: Excessive Sell-off Presents Buying Opportunity $5.14 Chris Reindler creindler@taylorcollison.com.au +61 2 9210 1335 Summary (AUD) Market
More informationCentrale del Latte d'italia
Centrale del Latte d'italia Sales improvement FY17 results Food & beverages Centrale del Latte d Italia s (CLI) price increases, implemented during H1, continue to drive revenue growth, with total revenue
More informationOneVue Holdings (OVH)
7 August 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 OneVue Holdings (OVH) FY17 result to show cost-out progress Recommendation
More informationHOLD BUY. China Singyes Solar Technologies [0750.HK] Outlook improving but positives largely priced in after recent share price rally
September February 27, 1, 2015 2016 China Singyes Solar Technologies [0750.HK] Outlook improving but positives largely priced in after recent share price rally Singyes s 1H16 earnings growth of 42% YoY
More informationQBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision
AUSTRALIA QBE AU Price (at 10:44, 27 Apr 2016 GMT) Neutral A$11.19 Valuation A$ - DCF (WACC 9.3%, beta 1.1, ERP 5.0%, RFR 3.8%) 11.34 12-month target A$ 12.00 12-month TSR % +12.7 Volatility Index Low/Medium
More informationMotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts
Date Theme Company Update Company MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction We moderate to HOLD (from Buy) with a revised target of $2.36 p/share. We were previously encouraged
More informationCREDIBLE LABS INC BUY. Partnership Marketing Strategy Paying Off EVENT COMPANY UPDATE HIGHLIGHTS INVESTMENT VIEW. Q4 Activities Report.
CREDIBLE LABS INC BUY Partnership Marketing Strategy Paying Off Diversified Financials / Other Diversified Financial Services 31 January 2019 COMPANY UPDATE Ticker CRD Stock Price $0.750 Target Price $1.470
More informationZip Co. Improved medium term cost guidance. Last Price A$0.96 Target Price A$1.00 (Previously A$0.90) Recommendation Accumulate Risk Higher
Improved medium term cost guidance Z1P s Jun-18 qtrly update outlined a beat against our cash flow expectations, with the company having generated positive operating cash flow (after bad debts) for the
More informationNoni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts
Date 09 January 2018 Theme Company Update Company Noni B (NBL) BUY: FY18e EBITDA +12.8% NBL provided a positive 1H18 trading update today, advising LFL sales growth of 3.0% (1.5% in 1H17) and EBITDA of
More informationFamily Zone Cyber Safety Limited (FZO) Company Update. Investment Summary. Investment Highlights. Investment Recommendation
BW EQUITIES RESEARCH 14 March 2017 Family Zone Cyber Safety Limited (FZO) Company Update BUY Rating: Target Price 1 : $0.46 Projected Return: 109% 1 12 month target Company Statistics Share Price (A$)
More informationNegotiating Cyclone project buy in
4 July 2017 Negotiating Cyclone project buy in Cape Bedford : High quality silica sand Recommendation Strong BUY, High Risk Price Valuation Products : 0.7c 6.5c Mineral Sands (Zircon rich) Silica sand
More informationOneVue Holdings (OVH)
24 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation Peter Arden 613 9235 1833 OneVue Holdings (OVH) Restructured and focused Recommendation Buy (unchanged) Price $0.745 Target (12 months)
More informationFisher & Paykel Healthcare
NEW ZEALAND FPH NZ Price (at 05:00, 10 Jul 2015 GMT) Outperform NZ$7.03 Valuation NZ$ 7.39 - DCF (WACC 8.8%, beta 0.9, ERP 7.0%, RFR 4.5%, TGR 2.0%) 12-month target NZ$ 7.80 12-month TSR % +13.1 Volatility
More informationCompany Review 1300SMILES. Corporate Activity Dental Partners. ONT A$6.72 (TP $6.26) Recommendation Hold (no change) Risk Assessment Medium
Ord Minnett Research 2 October 2013 1300SMILES Corporate Activity Dental Partners Event: A consortium led by private equity firm, Archer Capital has recently made an indicative offer for 100% of New Zealand
More informationPolish Coal : low cap.ex; low op.ex BMB has acquired 3 Polish coal projects. First coal, 2Mt/yr at $37/t from $50m cap.
30 September 2014 Polish Coal : low cap.ex; low op.ex BMB has acquired 3 Polish coal projects. First coal, 2Mt/yr at $37/t from $50m cap.ex, expected 2016 Recommendation Mariola thermal coal will be the
More informationNational Australia Bank
AUSTRALIA NAB AU Price (at 08:23, 03 Jul 2012 GMT) Outperform A$23.68 Volatility index Low 12-month target A$ 27.66 12-month TSR % +24.9 Valuation A$ - DCF (WACC 12.6%, beta 1.0, ERP 5.0%, RFR 5.8%) 25.14
More informationAPN Property Group (APD) Buy Share Price: A$0.41
APN Property Group (APD) Buy Share Price: A$0.41 Success in direct syndicates Target Price: A$0.51 Direct property syndicates have always been an integral part of the APN Property Group (APD) business.
More informationTPI Enterprises (TPE) BUY TERP: A$2.34
TPI Enterprises (TPE) BUY TERP: A$2.34 Company-Transforming Capital Raising Complete Target Price: A$3.55 TPI Enterprises (TPE) has undertaken a A$44.2M capital raising comprising a A$20.9M Placement and
More informationBoart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation
AUSTRALIA BLY AU Price (at 08:01, 12 Sep 2013 GMT) Neutral A$0.50 Valuation A$ 0.71 - DCF (WACC 10.1%, beta 1.5, ERP 0.1%, RFR 0.1%, TGR 0.0%) 12-month target A$ 0.56 12-month TSR % +12.0 Volatility Index
More informationAdani Ports & SEZ Rating: Target price: EPS:
Adani Ports & SEZ : price: EPS: Volume traction continues in a seasonally good quarter; maintain Adani Ports & SEZ reported a good quarter with total operating revenues (standalone) of Rs. 8.02bn and PAT
More informationCENTREPOINT ALLIANCE LIMITED (CAF)
Low Return High Financial Results 25 August 2014 CENTREPOINT ALLIANCE LIMITED (CAF) ACTION & RECOMMENDATION Financial planning and SME insurance premium funding business Centrepoint Alliance (ASX code:
More informationListed Managed Investments
Australian MANAGED INVESTMENTS ANALYSIS Listed Managed Investments March 2008 Quarterly Review EXTRACT Defensive strategies provide some downside protection in a volatile market Contents This is an extract
More informationSomnoMed (SOM) BUY: US channel conflicts abating in Q4. Key points. Risks and catalysts
Date 27 April 2017 Theme Company Update Company SomnoMed (SOM) BUY: US channel conflicts abating in Q4 We maintain a BUY rating and 12-month price target of $4.50 per share. SomnoMed s Q3 update was a
More informationBUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS
BUY 0.11 0.39 0.69 SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS CONTENTS Competitors Products Sales channels Pricing Model INVESTMENT THESIS COMPANY OVERVIEW INDUSTRY OVERVIEW COMPETITORS BOARD
More informationAPN Outdoor Group (APO)
26 June 2018 INTERNAL ONLY RECOMMENDATIONS Rating HOLD Risk Medium Price Target $6.70 Share Price $6.45 SNAPSHOT Monthly Turnover $323.7mn Market Cap $1,069mn Shares Issued 167.0mn 52-Week High $6.70 52-Week
More information1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following
FIRST BERLIN Equity Research M1 Kliniken AG RATING Germany / Healthcare Facilities & Services Update following Frankfurt PRICE TARGET 16.50 Bloomberg: M12 GR capital increase Return Potential 44.7% ISIN:
More informationAnhui Conch [0914.HK]
Anhui Conch [0914.HK] Due to high base effect in 1H14 and weak cement price trend year-to-date, we forecast Anhui Conch s 1H15 recurring net profit to decline 41% year-on-year (YoY) to RMB3.45bn. As a
More informationResult review. mln) Key forecast table (MYR
Result review Evergreen Fibreboard Hold To Buy Buy May 18, 2010 Materials Forest Products Malaysia Bloomberg EVF MK Reuters EVGN.KL Recommendation Buy Issuer credit rating Not Rated 12-month target price
More informationContango MicroCap Ltd (CTN)
Contango MicroCap Ltd (CTN) Listed Managed Investments September 2016 Quarterly Review WHO IS IIR? Independent Investment Research, IIR, is an independent investment research house based in Australia and
More informationPlatinum Asset Management
AUSTRALIA PTM AU Price (at 06:10, 11 Jul 2016 GMT) Neutral A$5.52 Valuation A$ - DCF (WACC 9.3%, beta 1.2, ERP 5.0%, RFR 3.3%) 5.19 12-month target A$ 5.36 12-month TSR % +2.6 Volatility Index Low/Medium
More information2011 Interim Results. Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer
2011 Interim Results Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer Emeco 2011 Interim Results Overview Financials Strategy & Outlook Questions Appendices
More informationMRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials
Company Update Automobile February 22, 212 MRF Performance Highlights Y/E Sept. (` cr) 1QSY12 1QSY11 % chg (yoy) 4QSY11 % chg (qoq) Net sales 2,875 2,167 32.7 2,62 9.8 EBITDA 258 243 5.9 181 42.6 EBITDA
More informationCooks Global Foods Ltd
Cooks Global Foods Ltd Company Update Gaining traction, restructure taking time Cooks Global Foods (CGF.NZAX) is a global integrated food and beverage retail and supply company headquartered in New Zealand.
More informationAMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation
AUSTRALIA AU Price (at CLOSE#, 19 Mar 213) Underperform A$5.7 Volatility index Low 12-month target A$ 4.99 12-month TSR % +3.6 Valuation - Sum of Parts A$ 4.68 GICS sector Insurance Market cap A$m 14,855
More information2014 E 2015 E 2016 E 2017 E
Equity Research 4 December 2014 Interpump Group Hydraulics M&A may power growth Rating BUY Target price EUR13 Interpump is up 25% since the beginning of the year, bolstered by strong interim results and
More informationChina Modern Dairy (1117 HK)
Equity Research Consumer staples China Modern Dairy (1117 HK) Underperform (Downgraded) Target price: HK$2.75 ASP outlook worsens on China Mengniu settlement price cut Milk powder inventory destocking
More informationRamsay Health Care. France begins to bite A$66.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst
AUSTRALIA RHC AU Price (at 06:11, 06 Aug 2015 GMT) Neutral A$66.37 Valuation A$ 64.54 - DCF (WACC 8.1%, beta 1.1, ERP 5.0%, RFR 3.8%, TGR 3.0%) 12-month target A$ 70.00 12-month TSR % +7.3 Volatility Index
More informationVery solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected
B a sl er A G # $T ypcap$ 1576 14 1 1 x 6495 2 Page 1/6 First Take Reco. lowered Neutral vs Buy Electronics Germany Neutral Target price : 60.00 EUR vs 52.00 EUR Price (11/01/2016) : 58.04 EUR Upside :
More informationSlater & Gordon Limited
BBY Company Research 29 November 2013 Slater & Gordon Limited SGH A$4.39 TARGET PRICE A$5.00 BUY 0.5X Slater & Gordon Limited (SGH) is a national law firm. The Firm's areas of practice include commercial,
More informationNTPC LIMITED RESEARCH
RESULTS REVIEW Share Data Market Cap Rs. 1,457.0 bn Price Rs. 176.70 BSE Sensex 9,201.85 Reuters NTPC.BO Bloomberg NATP IN Avg. Volume (52 Week) 2.06 mn 52-Week High/Low Rs. 227 / 113 Shares Outstanding
More informationASX: DDR FY16 Results Presentation. March 2017
ASX: DDR FY16 Results Presentation March 2017 Corporate Headlines Capital Structure Share Price (24 Mar 2017) $2.17 Fully paid ordinary shares 160.0m Options 0.0m Market Capitalisation $347.2m Shareholders
More informationHaitong Securities [6837.HK]
July 14, 2015 Haitong Securities [6837.HK] Solid 1H Result Provides Buffer; Margin Financing Risk Manageable We believe a 36% correction of Haitong Securities (HTS) share price since early June has been
More informationArgo Investments Limited (ARG)
Argo Investments Limited (ARG) Listed Managed Investments June 2017 Quarterly Review WHO IS IIR? Independent Investment Research, IIR, is an independent investment research house based in Australia and
More informationEddie Stobart Logistics
Eddie Stobart Logistics Interims show delivery on growth plans Interim results Industrial support services Eddie Stobart Logistics (ESL) H1 numbers, well trailed at the trading update in July, showed high
More informationCentrale del Latte d'italia
Centrale del Latte d'italia Strong revenue growth H117 results Food & beverages Price increases implemented during the course of H117 have been successful and organic sales growth of 4.8% is impressive.
More informationCompany Review. Centaurus Metals. Jambreiro Resource upgrade. CTM A$0.08 Recommendation Buy Risk Assessment High
Company Review Ord Minnett Research Friday, June 24, 2011 Centaurus Metals Jambreiro Resource upgrade Centaurus has upgraded the JORC resource at its flagship, Jambreiro Iron Ore Project in Brazil. The
More informationKey estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,
: price: EPS: How does our one year outlook change? We retain our negative stance on the stock. We expect s revenue to de-grow by 9% y-o-y on the back of muted execution (client side and clearance delays)
More information